{"nct_id":"NCT05935215","title":"Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)","status":"RECRUITING","status_verified_date":"2025-07","start_date":"2024-02-28","start_date_type":"ACTUAL","primary_completion_date":"2028-07-21","primary_completion_date_type":"ESTIMATED","completion_date":"2029-07-19","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}